Uncategorized

Regenative Labs announces advancements in breast reduction post-surgical complication care with Wharton’s jelly
Tyler Barrett, CEO of Regenative Labs
An electron microsope and computer screen of tissue
REGENATIVE LABS' STUDY OPENS THE DOOR FOR ADVANCED TREATMENT OF DEGENERATING TISSUE IN KNEE JOINTS
Regenative Labs announces groundbreaking Wharton's Jelly research demonstrating HCT/P compliance after processing
REGENATIVE LABS RELEASES NEW STUDY TO REVOLUTIONIZE TREATMENT FOR PATIENTS WITH DIABETIC FOOT ULCERS
REGENATIVE LABS AND AAPC ANNOUNCE COLLABORATION TO FURTHER HEALTHCARE COMPLIANCE
Application of Dehydrated Amniotic Membrane Allografts in Advanced Diabetic Foot Ulceration: Case Report and Review of Literature
Institutional Review Board Approves Regenative Labs’ Protocol For Key Data Collection
Next Page »